Anthill, HCG launch pro­gramme for HealthTech start-ups

BioSpectrum (India) - - START-UP NEWS -

Anthill Ven­tures, an in­vest­ment and scal­ing plat­form for early growth stage start-ups, has an­nounced its part­ner­ship with Health­Care Global En­ter­prises Ltd. (HCG), the largest provider of can­cer care in In­dia, to launch a mar­ket ac­cess pro­gramme for HealthTech start-ups. Lu­mos is a 12-month pro­gramme de­signed for HealthTech star­tups with dis­rup­tive so­lu­tions and tech­nolo­gies within the core busi­nesses of HCG which in­clude on­col­ogy, fer­til­ity, pre­ci­sion medicine, ge­nomics, re­search and di­ag­nos­tics, as well as emerg­ing ar­eas across the health­care ecosys­tem. Anthill and HCG, along with their net­work of in­vestors will in­vest up to $1 mil­lion in the HealthTech start-ups. The start-ups will also have ac­cess to new cus­tomers, get busi­ness men­tor­ing and sup­port in their growth jour­ney, ac­cess to high end en­vi­ron­ment for faster prod­uct de­vel­op­ment, plat­form to show­case their prod­ucts to the right mar­ket and op­por­tu­nity to work on pi­lot projects through part­ner­ships with cor­po­rates.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.